Skip to main content
The Markets by Proactive
Go to Proactive UK
Proactive UK has moved. Proactive’s coverage of London’s small caps continues on proactiveinvestors.com Go there →
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Coverage of London’s small caps continues on proactiveinvestors.com
Go to Proactive UK
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK

Archive

GreenBank Capital new CEO talks through CodiKoat's trial results for its anti-viral coating product

GreenBank Capital new CEO talks through CodiKoat's trial results for its anti-viral coating product

GreenBank Capital (CSE:GBC) Inc (CSE:GBC) CEO Terry Pullen joined Proactive to discuss its portfolio company CodiKoat, which he says has successfully completed pilot tests of its GoVirol anti-viral coating product.

The tests were conducted at the Royal Opera House in London by Codikoat's own scientists over three months from the middle of May to the middle of August 2021. Pullen says he has high hopes for the positive health impact that the CodiKoat technology may have in the healthcare, touch screen device and hospitality sectors.

Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK